Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. id=”article-body” class=”row” section=”article-body”> We didn’t see him unmasked until 77-year-old Sebastian Shaw portrayed him briefly in 1983’s “Return of the […]
READ MORE